| Exploring solubility enhancement of poorly soluble biopharmaceutics classification system class II drug axitinib, comprises designing and developing fast dissolving axitinib tablet using liquisolid technique; optimizing carriers and coating materials that facilitate enhanced dissolution rate | |
| 2023-08-16 | |
| 专利权人 | DHOLE R S (DHOL-Individual) ; GHATAGE G A (GHAT-Individual) ; DOL H S (DOLH-Individual) ; PATIL K S (PATI-Individual) ; HAJARE A A (HAJA-Individual) ; VARNE P B (VARN-Individual) |
| 申请日期 | 2023-08-16 |
| 专利号 | IN202321054776-A |
| 成果简介 | NOVELTY - Exploring the solubility enhancement of poorly soluble biopharmaceutics classification system (BCS) class II drug axitinib, comprises designing and developing fast dissolving axitinib tablet using liquisolid technique; optimizing carriers and coating materials that facilitate enhanced dissolution rate of axitinib through liquisolid tablet. USE - Method for exploring the solubility enhancement of poorly soluble biopharmaceutics classification system (BCS) class II drug axitinib (claimed). ADVANTAGE - The method improves dissolution rate of axitinib through liquisolid tablet formulation. |
| IPC 分类号 | A61K-031/4439 ; A61K-047/12 ; A61K-047/22 ; A61K-047/26 ; A61K-009/20 ; A61P-013/12 ; A61P-035/00 |
| 国家 | 印度 |
| 专业领域 | 医药卫生 |
| 语种 | 英语 |
| 成果类型 | 专利 |
| 文献类型 | 科技成果 |
| 条目标识符 | http://119.78.100.226:8889/handle/3KE4DYBR/20799 |
| 专题 | 中国科学院新疆生态与地理研究所 |
| 作者单位 | 1.DHOLE R S (DHOL-Individual) 2.GHATAGE G A (GHAT-Individual) 3.DOL H S (DOLH-Individual) 4.PATIL K S (PATI-Individual) 5.HAJARE A A (HAJA-Individual) 6.VARNE P B (VARN-Individual) |
| 推荐引用方式 GB/T 7714 | DHOLE R S,GHATAGE G A,DOL H S,et al. Exploring solubility enhancement of poorly soluble biopharmaceutics classification system class II drug axitinib, comprises designing and developing fast dissolving axitinib tablet using liquisolid technique; optimizing carriers and coating materials that facilitate enhanced dissolution rate. IN202321054776-A[P]. 2023. |
| 条目包含的文件 | 条目无相关文件。 | |||||
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论